CSX Corp (NASDAQ: CSX) Q4 2020 earnings call dated Jan. 21, 2021
Corporate Participants:
Bill Slater — Chief Investor Relations Officer
James M. Foote — President and Chief Executive Officer
Kevin Boone — Executive Vice President and Chief Financial Officer
Jamie Boychuk — Executive Vice President of Operations
Analysts:
Brandon Oglenski — Barclays — Analyst
Ken Hoexter — Bank of America — Analyst
Amit Mehrotra — Deutsche Bank — Analyst
Allison Landry — Credit Suisse — Analyst
Tom Wadewitz — UBS — Analyst
Justin Long — Stephens — Analyst
Scott Group — Wolfe Research — Analyst
Chris Wetherbee — Citigroup — Analyst
Bascome Majors — Susquehanna — Analyst
Brian Ossenbeck — JPMorgan — Analyst
David Vernon — Bernstein — Analyst
Jon Chappell — Evercore ISI — Analyst
Jordan Alliger — Goldman Sachs — Analyst
Jason Seidl — Cowen — Analyst
Ravi Shanker — Morgan Stanley — Analyst
Walter Spracklin — RBC Capital Markets — Analyst
David Ross — Stifel — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Listen On
